What is Syndax Pharmaceuticals's net change in cash?

Syndax Pharmaceuticals (SNDX) reported net change in cash of -$4.04M in Q1 2026.

How has Syndax Pharmaceuticals's net change in cash changed year-over-year?

Syndax Pharmaceuticals's net change in cash decreased by 4385.6% year-over-year, from -$90K to -$4.04M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Syndax Pharmaceuticals SNDX Net Change in Cash

Net Change in Cash at other companies

BiogenBIIB

$392.2M+108%

IncyteINCY

$363.28M+43.1%

SELLAS Life Sciences Group, Inc.SLS

$35.3M+143%

AbbVieABBV

$4.16B+1,293%

ArriVent BioPharma, Inc.AVBP

$16.56M+168%

Viridian Therapeutics, Inc.VRDN

-$36.04M-317%

Other financials

Income statement

See full

Revenue$64.9M+224%

Operating income-$34.2M+59.2%

Net income-$42.7M+49.7%

EPS (diluted)-$0.48+51.0%

Balance sheet

See full

Cash & equivalents$130.9M-15.0%

Total debt$350.5M+4.2%

Total equity$41.6M-80.6%

Total assets$472.7M-26.2%

Cash flow

See full

Operating cash flow-$50.3M+47.1%

CapEx$46.8K—

Free cash flow-$80.8M-17.6%

Valuation

See full

Market cap$1.74B+95.0%

Enterprise value$1.96B+84.0%

P/S8×-12.4×

Profitability

See full

Operating margin-102.8%-47.8pp

Net margin-111.9%-51.5pp

FCF margin-187.2%-85.4pp

Returns & leverage

See full

Return on equity-189.5%-8,509pp

Debt / equity8.4×+6.9×

Current ratio5.5×-0.3×

Where this comes from

Reported directly by Syndax Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Syndax Pharmaceuticals's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Syndax Pharmaceuticals's net change in cash?: Syndax Pharmaceuticals (SNDX) reported net change in cash of -$4.04M in Q1 2026.
How has Syndax Pharmaceuticals's net change in cash changed year-over-year?: Syndax Pharmaceuticals's net change in cash decreased by 4385.6% year-over-year, from -$90K to -$4.04M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.